These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Update on the treatment of Parkinson's disease. Wirz D Conn Med; 1985 Oct; 49(10):633-7. PubMed ID: 3933903 [No Abstract] [Full Text] [Related]
6. Treatment of Parkinson's disease. From theory to practice. Ahlskog JE Postgrad Med; 1994 Apr; 95(5):52-4, 57-8, 61-4 passim. PubMed ID: 8153048 [TBL] [Abstract][Full Text] [Related]
7. Update on the management of Parkinson's disease. Standaert DG; Stern MB Med Clin North Am; 1993 Jan; 77(1):169-83. PubMed ID: 8093493 [TBL] [Abstract][Full Text] [Related]
8. Practical therapeutics: advances in the management of Parkinson's disease. Adam AM East Afr Med J; 1985 Feb; 62(2):143-6. PubMed ID: 3930202 [No Abstract] [Full Text] [Related]
9. [Drug therapy of Parkinson's disease]. Myllylä V Duodecim; 1997; 113(18):1827-34. PubMed ID: 10892076 [No Abstract] [Full Text] [Related]
10. Drugs for parkinsonism. Med Lett Drugs Ther; 1986 Jun; 28(716):62-4. PubMed ID: 3713639 [No Abstract] [Full Text] [Related]
11. Therapy of Parkinson's disease: are we at the end of the road? Nag D J Assoc Physicians India; 1992 Jun; 40(6):361-3. PubMed ID: 1360470 [No Abstract] [Full Text] [Related]
12. Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality. Aaltonen H; Kilkku O; Heinonen E; Mäki-Ikola O BMJ; 1998 Dec; 317(7172):1586-7. PubMed ID: 9890764 [No Abstract] [Full Text] [Related]
13. Pharmacological approaches to Parkinson's disease in the different phases of evolution. Giovannini P; Piccolo I; Scigliano G; Caraceni T J Neural Transm Suppl; 1986; 22():173-87. PubMed ID: 3097255 [TBL] [Abstract][Full Text] [Related]
15. Selegiline: a second look. Six years later: too risky in Parkinson's disease. Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263 [TBL] [Abstract][Full Text] [Related]
16. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias. Mark MH; Sage JI Ann Clin Lab Sci; 1994; 24(1):12-21. PubMed ID: 8147565 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors. Henchcliffe C; Schumacher HC; Burgut FT Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338 [TBL] [Abstract][Full Text] [Related]
18. Drugs for parkinsonism. Med Lett Drugs Ther; 1979 May; 21(9):37-8. PubMed ID: 449844 [No Abstract] [Full Text] [Related]